Cargando…
Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma: Past, Present, and Future
High-dose melphalan (200 mg/m(2)) as conditioning regimen followed by autologous stem cell transplantation (ASCT) rescue has been established as a standard treatment for patients with multiple myeloma (MM) younger than 65 years of age. However, the role of ASCT in elderly patients older than 65 year...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956410/ https://www.ncbi.nlm.nih.gov/pubmed/24719860 http://dx.doi.org/10.1155/2014/394792 |